Brief: Hls Therapeutics Announces Reimbursement For Vascepa Under Nova Scotia's Provincial Drug Plan
02/07/2025 12:03
July 2 (Reuters) - HLS Therapeutics Inc HLS.TO: HLS THERAPEUTICS ANNOUNCES REIMBURSEMENT FOR VASCEPA® UNDER NOVA SCOTIA'S PROVINCIAL DRUG PLAN HLS THERAPEUTICS INC - PLA WITH NOVA SCOTIA PHARMACARE EFFECTIVE JULY 1, 2025 Source text: ID:nCNWLl02Na Further company coverage: HLS.TO (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group